DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Giovannoni G, Kappos L, Gold R. , et al.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: an integrated analysis of clinical studies.
Mult Scler Relat Disord 2016;
9: 36-46
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.